Follow
Mark A. Kay
Mark A. Kay
Verified email at stanford.edu
Title
Cited by
Cited by
Year
Progress and problems with the use of viral vectors for gene therapy
CE Thomas, A Ehrhardt, MA Kay
Nature Reviews Genetics 4 (5), 346-358, 2003
32002003
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
CS Manno, GF Pierce, VR Arruda, B Glader, M Ragni, JJE Rasko, ...
Nature medicine 12 (3), 342-347, 2006
23262006
Adenovirus-associated virus vector–mediated gene transfer in hemophilia B
AC Nathwani, EGD Tuddenham, S Rangarajan, C Rosales, J McIntosh, ...
New England Journal of Medicine 365 (25), 2357-2365, 2011
20872011
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
D Grimm, KL Streetz, CL Jopling, TA Storm, K Pandey, CR Davis, ...
Nature 441 (7092), 537-541, 2006
20552006
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
MA Kay, JC Glorioso, L Naldini
Nature medicine 7 (1), 33-40, 2001
18372001
RNA interference in adult mice
AP McCaffrey, L Meuse, TTT Pham, DS Conklin, GJ Hannon, MA Kay
Nature 418 (6893), 38-39, 2002
16532002
Long-term safety and efficacy of factor IX gene therapy in hemophilia B
AC Nathwani, UM Reiss, EGD Tuddenham, C Rosales, P Chowdary, ...
New England Journal of Medicine 371 (21), 1994-2004, 2014
13292014
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay, CS Manno, MV Ragni, PJ Larson, LB Couto, A McClelland, ...
Nature genetics 24 (3), 257-261, 2000
13042000
Inhibition of hepatitis B virus in mice by RNA interference
AP McCaffrey, H Nakai, K Pandey, Z Huang, FH Salazar, H Xu, ...
Nature biotechnology 21 (6), 639-644, 2003
9852003
A nonviral minicircle vector for deriving human iPS cells
F Jia, KD Wilson, N Sun, DM Gupta, M Huang, Z Li, NJ Panetta, ZY Chen, ...
Nature methods 7 (3), 197-199, 2010
9402010
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
CS Manno, AJ Chew, S Hutchison, PJ Larson, RW Herzog, VR Arruda, ...
Blood, The Journal of the American Society of Hematology 101 (8), 2963-2972, 2003
8892003
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice
H Azuma, N Paulk, A Ranade, C Dorrell, M Al-Dhalimy, E Ellis, S Strom, ...
Nature biotechnology 25 (8), 903-910, 2007
8652007
State-of-the-art gene-based therapies: the road ahead
MA Kay
Nature Reviews Genetics 12 (5), 316-328, 2011
8302011
Sarcoma derived from cultured mesenchymal stem cells
J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, ...
Stem cells 25 (2), 371-379, 2007
8042007
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses
D Grimm, JS Lee, L Wang, T Desai, B Akache, TA Storm, MA Kay
Journal of virology 82 (12), 5887-5911, 2008
7672008
In vivo activity of nuclease-resistant siRNAs
JM Layzer, AP McCaffrey, AK Tanner, ZAN Huang, MA Kay, BA Sullenger
Rna 10 (5), 766-771, 2004
7542004
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
RO Snyder, CH Miao, GA Patijn, SK Spratt, O Danos, D Nagy, AM Gown, ...
Nature genetics 16 (3), 270-276, 1997
7331997
Human tRNA-derived small RNAs in the global regulation of RNA silencing
D Haussecker, Y Huang, A Lau, P Parameswaran, AZ Fire, MA Kay
Rna 16 (4), 673-695, 2010
7312010
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8
K Inagaki, S Fuess, TA Storm, GA Gibson, CF Mctiernan, MA Kay, H Nakai
Molecular Therapy 14 (1), 45-53, 2006
7152006
Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system
SR Yant, L Meuse, W Chiu, Z Ivics, Z Izsvak, MA Kay
Nature genetics 25 (1), 35-41, 2000
6262000
The system can't perform the operation now. Try again later.
Articles 1–20